{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/deep-vein-thrombosis/have-i-got-the-right-topic/","result":{"pageContext":{"chapter":{"id":"bf477005-0407-58ad-9621-2529440a1912","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","depth":1,"htmlHeader":"<!-- begin field 82b9e049-8383-4d37-aefb-6085499ba129 --><h1>Have I got the right topic?</h1><!-- end field 82b9e049-8383-4d37-aefb-6085499ba129 -->","summary":null,"htmlStringContent":"<!-- begin item 91a0c61f-2129-4e14-9ed0-b89719ee9b15 --><!-- begin field f0981df3-f238-4463-9f0b-acbc01560324 --><p>From age 16 years onwards.</p><!-- end field f0981df3-f238-4463-9f0b-acbc01560324 --><!-- begin field 52060916-3a3f-4e10-95a5-14d8f94efbf6 --><p>This CKS topic is largely based on the National Institute for Health and Care Excellence (NICE) guideline <em>Venous thromboembolic diseases: diagnosis, management and thrombophilia testing </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/deep-vein-thrombosis/references/\">NICE, 2020</a>], the British Medical Journal (BMJ) best practice guide <em>Deep vein thrombosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/deep-vein-thrombosis/references/\">BMJ, 2019</a>], and the Scottish Intercollegiate Guidelines Network (SIGN) guideline <em>Prevention and management of venous thromboembolism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/deep-vein-thrombosis/references/\">SIGN, 2014</a>].</p><p>This CKS topic covers the identification and management of suspected deep vein thrombosis (DVT) and the subsequent prevention of venous thromboembolism (VTE).</p><p>This CKS topic does not cover the management of DVT and VTE in hospital, or the primary prevention of DVT. It does not cover the management of people with coagulation disorders or with recurrent DVT who require long-term anticoagulation.</p><p>There are separate CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/leg-cramps/\">Leg cramps</a>, <a class=\"topic-reference external-reference\" href=\"/topics/leg-ulcer-venous/\">Leg ulcer - venous</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/\">Thrombophlebitis - superficial</a>. For information on prescribing issues associated with warfarin, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anticoagulation-oral/\">Anticoagulation - oral</a>. For information on the so-called 'economy class syndrome', see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dvt-prevention-for-travellers/\">DVT prevention for travellers</a>. Information on the risk of VTE related to oestrogen therapy can be found in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/menopause/\">Menopause</a>.</p><p>The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.</p><!-- end field 52060916-3a3f-4e10-95a5-14d8f94efbf6 --><!-- end item 91a0c61f-2129-4e14-9ed0-b89719ee9b15 -->","topic":{"id":"c1b45e75-436b-56a1-a385-f8422d715e82","topicId":"a4df6bb3-1690-4ec4-9cba-0dcff60cc7ef","topicName":"Deep vein thrombosis","slug":"deep-vein-thrombosis","lastRevised":"Last revised in November 2020","chapters":[{"id":"043e731c-3abf-53ee-a31d-8d884bd3bc70","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bf477005-0407-58ad-9621-2529440a1912","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0d6b5798-088f-5468-84b7-a93cfe9e70d4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c5e88810-6d89-56ef-9120-966cbdac34da","slug":"changes","fullItemName":"Changes"},{"id":"06d2c305-090e-5332-b7a1-b6be267bcd41","slug":"update","fullItemName":"Update"}]},{"id":"0e61afec-aecd-50f3-8f6d-ef8da1dc9003","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"acd9fd74-ef09-56e2-b4e4-65e22ddc6269","slug":"goals","fullItemName":"Goals"},{"id":"13b37b76-163e-58e7-9ed4-add17978eb23","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c283b01d-3860-51e0-bb61-d68a12c34e68","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6c0366d1-9980-5dc1-8946-44e5030bc691","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"707aca3b-1b4f-52aa-848d-6d44d4337f41","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b9c8c09-f068-59bc-ad89-ca508289d1b7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"341b7f8d-b4d0-58b0-8198-4c563cb9f40e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b31fd103-9bbb-5216-ad96-7ce04f610584","slug":"definition","fullItemName":"Definition"},{"id":"f95afcb9-845a-579a-a5bd-b95f7163d1b9","slug":"incidence","fullItemName":"Incidence"},{"id":"fb6ff0cb-ba3b-5075-9e5e-52380bc0ecd3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b828ffa2-5a2d-5a7d-89c2-3b5ce4c27b07","slug":"complications","fullItemName":"Complications"}]},{"id":"837dc43f-aac0-51fa-af65-afb4b7a54467","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"699e0a9f-a13f-535b-91e2-967968d57b5e","slug":"when-to-suspect-dvt","fullItemName":"When to suspect DVT"},{"id":"e436c043-ce99-5fc5-b99e-deb107b997e9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9caf86d2-a390-5cb8-bcec-dd055468ba41","fullItemName":"Management","slug":"management","subChapters":[{"id":"edd98243-d8d1-5402-a55c-9d8de8e68068","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"02795cd7-4068-5ef2-840c-914a96cfd71b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"15bc2153-6b1c-5a58-9c8d-25d9978f2dde","slug":"parenteral-anticoagulants","fullItemName":"Parenteral anticoagulants"},{"id":"7e7201d1-4e56-53ec-95ac-c64ea70060e4","slug":"oral-anticoagulants","fullItemName":"Oral anticoagulants"}]},{"id":"a5e9e695-9150-5486-8075-1fa6c8b75fba","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"06671f87-530c-52a1-800c-749cdb70cad7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"63cf38fe-dc13-5253-93e7-bb3da5b958a1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"439fde91-9bb2-561f-8d66-de440bc5e387","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0f076b49-f0f3-597a-ba30-f5f3f414beae","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5e81047f-a3c4-52f4-ad24-f951952ea809","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"17391681-76bf-5417-9a9c-6e66245c631d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2cd34860-5410-5109-8de9-0227c8af1e62","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}